Encompass Health Corp (NYSE: EHC) has reported earnings for its second fiscal quarter (ending June 30) of $1.14 versus $0.92 for the same period a year ago — an increase of 24%. This result exceeded the consensus estimate of $1.01 by $0.13. For the latest four quarters through June 30, E.P.S. were $4.10 versus $3.36 for the same period a year ago — an increase of 22%.
Recent Price Action
Encompass Health Corp (NYSE: EHC) stock closed at $89.67 on 8/5/24 after a decline of -3.3%. Moreover, this decline was accompanied by unusually high trading volume at 193% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -2.1% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, EHC is expected to continue to be a major Value Builder.
Encompass Health has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Encompass Health has a poor Appreciation Score of 15 but a very high Power Rating of 88, and the Neutral Value Trend Rating results.
Rating Review
In light of this encouraging new earnings information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment